Stifel Financial Corp Sells 299,669 Shares of Aemetis, Inc. (NASDAQ:AMTX)

Stifel Financial Corp trimmed its position in shares of Aemetis, Inc. (NASDAQ:AMTX - Free Report) by 41.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 419,494 shares of the specialty chemicals company's stock after selling 299,669 shares during the period. Stifel Financial Corp owned 0.84% of Aemetis worth $965,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. FMR LLC lifted its stake in shares of Aemetis by 68.2% during the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company's stock valued at $52,000 after buying an additional 9,137 shares in the last quarter. Hutchinson Capital Management CA purchased a new stake in shares of Aemetis during the second quarter worth $70,000. Rhumbline Advisers boosted its holdings in shares of Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company's stock worth $157,000 after acquiring an additional 50,528 shares during the period. Susquehanna Fundamental Investments LLC grew its position in shares of Aemetis by 287.4% in the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company's stock valued at $379,000 after purchasing an additional 93,536 shares in the last quarter. Finally, Bank of New York Mellon Corp bought a new stake in shares of Aemetis during the 2nd quarter valued at $306,000. 27.02% of the stock is owned by hedge funds and other institutional investors.

Aemetis Stock Performance

Aemetis stock traded up $0.04 during mid-day trading on Tuesday, hitting $2.63. 363,140 shares of the company traded hands, compared to its average volume of 793,738. The stock has a fifty day moving average price of $3.30 and a 200-day moving average price of $3.00. The stock has a market cap of $130.80 million, a price-to-earnings ratio of -1.16 and a beta of 1.35. Aemetis, Inc. has a one year low of $2.10 and a one year high of $7.03.

Aemetis (NASDAQ:AMTX - Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, beating analysts' consensus estimates of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to the consensus estimate of $77.79 million. During the same quarter in the previous year, the business earned ($0.59) earnings per share. Sell-side analysts predict that Aemetis, Inc. will post -2.02 EPS for the current year.

Analyst Ratings Changes

AMTX has been the subject of several analyst reports. HC Wainwright restated a "buy" rating and issued a $28.00 target price on shares of Aemetis in a research note on Monday. Ascendiant Capital Markets reduced their price objective on shares of Aemetis from $20.00 to $19.00 and set a "buy" rating for the company in a research note on Tuesday, September 3rd. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, Aemetis has a consensus rating of "Moderate Buy" and an average price target of $12.95.

Aemetis Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.